Venture Capital for Breakthrough Therapies
Doing Well by Doing Good
HealthCap is a life science investor and company creator. Our motivation is to find innovative ideas and invest in people and companies that could impact healthcare and society. Together with our stakeholders, we strive to make a real impact and create a better world.
127portfolio companies financed
33approved pharmaceutical products
47IPO’s on fourteen different markets
>5million patients treated
Making an Impact
HealthCap was founded in 1996 and has since worked actively to foster the life science ecosystem both locally and globally. Our companies treat millions of patients throughout the world.
Team of Professionals
HealthCap has medical knowledge in its DNA. We are a dedicated team with broad and thorough expertise, spanning from medicine to finance and biochemistry. To be successful, we challenge current medical paradigms to explore new ways of treating – or even curing – diseases, to significantly improve quality of life.
Responsible Investment Strategy
HealthCap is looking to back companies developing targeted therapies for rare diseases, cancers, and genetic diseases. We are primarily focused on emerging therapeutics with a high unmet medical need. We take pride in collaborating with different groups including investors, the academic community, portfolio companies and patients, as well as other key players in society. Having a responsible and sustainable approach to investment and ownership is our way of creating value for our stakeholders.
November 27, 2023Priothera – US FDA grants Orphan Drug Designation to mocravimod to improve the outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with hematologic malignancies
November 17, 2023Invitation to BONESUPPORT’s Capital Markets Day
November 17, 2023Article with exploratory alkylator-refractory subgroup analysis from Oncopeptides’ OCEAN study observing longer PFS and OS in melflufen vs. pomalidomide published in European Journal of Haematology